PRAX
Praxis Precision Medicines Inc.
$181.99
-$16.77(-8.44%)
60
Overall
60
Value
75
Tech
47
Quality
Market Cap
$4.20B
Volume
1.74M
52W Range
$26.70 - $206.71
Target Price
$288.21
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | -- | -- | -- | $2.4M | $8.6M | ||
| Total Revenue | -- | -- | -- | $2.4M | $8.6M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | $2.4M | $8.6M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $62.0M | $167.3M | $215.0M | $128.8M | $208.7M | ||
| Research & Development | $45.0M | $120.3M | $155.0M | $86.8M | $152.4M | ||
| Research Expense | $45.0M | $120.3M | $155.0M | $86.8M | $152.4M | ||
| Selling, General & Administrative | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
| General & Administrative Expenses | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
| Salaries & Wages | -- | -- | -- | $24.9M | $41.4M | ||
| Depreciation & Amortization | $50.0K | $182.0K | $419.0K | $432.0K | $358.0K | ||
| Depreciation & Amortization | $50.0K | $182.0K | $419.0K | $432.0K | $358.0K | ||
| Other Operating Expenses | $796.0K | $1.4M | $1.1M | $1.1M | $1.1M | ||
| OPERATING INCOME | |||||||
| Operating income | $-62.0M | $-167.3M | $-215.0M | $-126.4M | $-200.2M | ||
| EBITDA | $-61.9M | $-167.2M | $-214.6M | $-122.0M | $-181.5M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | $140.0K | $271.0K | $957.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $140.0K | $271.0K | $957.0K | -- | -- | ||
| Other Income/Expense | -- | -- | $957.0K | $-3.1M | $-17.3M | ||
| Other Special Charges | -- | -- | $957.0K | $3.1M | $17.3M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | -- | $1.0M | -- | -- | ||
| Special Income Charges | -- | -- | $-1.0M | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-62.0M | $-167.3M | $-215.0M | $-123.3M | $-182.8M | ||
| Pre-Tax Income | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
| INCOME TAX | |||||||
| Tax Provision | $-8.0K | -- | -- | -- | -- | ||
| NET INCOME | |||||||
| Net Income | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
| Net Income (Continuing Operations) | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
| Net Income (Discontinued Operations) | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
| Net Income (Common Stockholders) | $-70.3M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
| Normalized Income | -- | -- | -- | -- | $-181.0M | ||
| TOTALS | |||||||
| Total Expenses | $62.0M | $167.3M | $215.0M | $128.8M | $208.7M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $596.7K | $2.8M | $3.1M | $6.6M | $17.9M | ||
| Average Shares Outstanding (Diluted) | -- | $2.8M | $3.1M | $6.6M | $17.9M | ||
| Shares Outstanding | $2.6M | $3.0M | $3.5M | $13.2M | $20.2M | ||
| Basic EPS | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
| Basic EPS (Continuing Operations) | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
| Diluted EPS | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
| Diluted EPS (Continuing Operations) | -- | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
| OTHER METRICS | |||||||
| Accrued Preferred Stock Dividends | $8.5M | -- | -- | -- | -- | ||
| Other Gand A | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
| Otherunder Preferred Stock Dividend | $8.5M | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $8.5M | -- | -- | -- | -- | ||
| Restruct | -- | -- | $1.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRAX | $181.99 | -8.4% | 1.74M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Praxis Precision Medicines Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW